Lexicon: Q4 Financial Results Overview

Lexicon Pharmaceuticals Reports Fourth Quarter Financial Results

Lexicon Pharmaceuticals Inc., headquartered in The Woodlands, Texas, announced on Thursday that it recorded a net loss of $15.5 million for the fourth quarter.

During this period, the company reported a per-share loss of 4 cents.

These figures surpassed the expectations of Wall Street analysts, who, according to a Zacks Investment Research survey of three experts, had anticipated a loss of 7 cents per share.

The pharmaceutical company generated $5.5 million in revenue for the quarter.

For the full year, Lexicon Pharmaceuticals reported a total loss of $50.3 million, translating to 14 cents per share, with annual revenue reaching $49.8 million.